How can automation help in the discovery of biologics?


Zoe Hughes-Thomas, GSK, will be discussing the ways in which Automation Can Help With The Discovery of Biologics and Biosimilars at the new Tech Theatre at this year’s ELRIG Drug Discovery, supported by DDW.

Hughes-Thomas is Associate Director, Head Medicine Design Automation, GSK.

The Tech Theatre will feature a series of seminars focused on automation and technology for drug discovery. 

The event will take place on 4-5 Oct, London Excel, UK and topics will include:

  • Taking first steps towards liquid handling automation
  • The role of AI and automation in personalised medicine: How can AI help in the post drug discovery process
  • Data handling and choosing the right informatics systems for your lab requirements
  • How can automation help the discovery of biologics and biosimilars?
  • The lab of the future is now: Using AI or automation for the discovery process
  • The sustainable lab. Building a global culture of sustainability in science
  • The automated lab and the human
  • The remote lab: Is this the future?

Seminars are free to attend but spaces are limited and require advanced registration. Click here now to register. 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free